GSK (GSK)

Deborah Waterhouse is the President of Global Health at GSK and has been part of the GSK Leadership Team since January 2020, after joining GSK in 1996. " Previously, she served as CEO of ViiV Healthcare since April 2017 and held several senior roles within GSK. "

James Ford is the Senior Vice President (SVP) and Group General Counsel, Legal and Compliance at GSK, having joined the GSK Leadership Team in 2018 and expanded his responsibilities in 2021. " " " He has been with GSK since 1995, serving in multiple senior legal roles. "

Julie Brown has been serving as GSK's CFO since 1 May 2023 after being appointed on 3 April 2023. " " She is an Executive Director on the Board and brings extensive financial leadership experience, with an upcoming role as Non-Executive Director and Chair of the Audit Committee at Diageo plc. "

Luke Miels has been the Chief Commercial Officer at GSK since 2017, overseeing the company’s commercial portfolio of medicines and vaccines. He also co-chairs the Portfolio Investment Board and serves on the ViiV Healthcare Board. " " "

Regis Simard has been serving as President, Global Supply Chain at GSK since 2018, overseeing the manufacturing and supply of GSK's medicines and vaccines. " " " He began his GSK career in 2005 as a Site Director in France and advanced to Senior Vice President of Global Pharmaceuticals Manufacturing before his current role. "

David Redfern joined GSK in 1994 and was appointed to the GSK Leadership Team as Chief Strategy Officer in 2008, later becoming President, Corporate Development. " " "

Diana Conrad is the Chief People Officer at GSK and has been a member of the GSK Leadership Team since April 2019. " " Previously, she served in senior HR roles for Pharmaceuticals R&D and Consumer Healthcare, playing key roles in transforming HR strategies. "

Phil Thomson has served as President, Global Affairs at GSK since 2017, where he drives strategic stakeholder engagement and policy development. " Previously, he was Senior Vice President, Communications and Government Affairs, and he began his career at Glaxo Wellcome in 1996. "

Sally Jackson is the Senior Vice President (SVP), Global Communications and CEO Office at GSK, where she leads global communications and government affairs and serves as the CEO's Chief of Staff. She has been with GSK since 2001 and joined the GSK Leadership Team in March 2019, marking a significant ascent in her career at the company. " " "

Chief Digital and Technology Officer at GSK since 2021, instrumental in driving digital transformation; previously, led Digital and Technology for GSK’s Global Commercial Organisation from 2018 to 2021. " "

Tony Wood has been the Chief Scientific Officer at GSK since August 1, 2022. " " He joined GSK in 2017 as Senior Vice President, Medicinal Science and Technology and previously led drug discovery and development at Pfizer. "

Charles Bancroft is a Senior Independent Non-Executive Director at GSK since July 18, 2022 and chairs the Audit & Risk Committee; he previously served in senior financial roles at Bristol Myers Squibb including CFO and other executive positions. " " "

Dr. Anne Beal is an Independent Non-Executive Director and Chair of the Corporate Responsibility Committee at GSK, bringing extensive experience as a physician, entrepreneur, and health policy expert. " " " She is known for her work in patient advocacy and driving GSK's ESG initiatives. " "

Dr. Gavin Screaton joined GSK as a Non-Executive Director on 1 May 2025 and serves on both the GSK Board Science Committee and the Corporate Responsibility Committee. " " Previously, he held roles including Head of Medical Sciences Division at the University of Oxford, Non-Executive Director of Oxford University Hospitals NHS Foundation Trust, Trustee of the Jenner Vaccine Foundation, and Co-founder of RQ Bio. "

Dr Hal Barron served as Chief Scientific Officer and President, R&D starting April 1, 2018 before transitioning to his current role as Non-Executive Director on August 1, 2022. " " He has vast biosciences experience, having held senior roles at Calico LLC, Roche, and Genentech. "

Dr. Harry (Hal) Dietz is an Independent Non-Executive Director at GSK, appointed on 1 January 2022. " He is a world-leading expert in human genetics with significant contributions in the field of Marfan Syndrome and the development of novel therapies. " "

Dr Jeannie Lee is an Independent Non-Executive Director at GSK, joining the Board on March 4, 2024 and recognized as a renowned expert in RNA Biology with significant contributions in academia and biotech innovation. " " " "

Dr. Vishal Sikka serves as an Independent Non-Executive Director at GSK since July 18, 2022. " " He brings deep expertise in AI, ML, and cybersecurity with prior leadership roles as CEO of Infosys and Founder of Vianai Systems. "

Elizabeth McKee Anderson has served as the Independent Non-Executive Director at GSK since 1 September 2022. " " " She brings extensive experience from her roles in commercial biopharmaceuticals at Janssen Pharmaceuticals and Wyeth Vaccines, and she contributes valuable expertise through her board participation at BioMarin. "

Sir Jonathan Symonds, a seasoned finance and life sciences expert, has served as GSK's Non-Executive Chair since 1 September 2019. " Previously, he held roles such as Independent Non-Executive Director at HSBC and CFO positions at Novartis and AstraZeneca. " " "

Wendy Becker has served as an Independent Non-Executive Director at GSK since October 1, 2023, and brings extensive experience from leadership roles including CEO at Jack Wills Limited and Group Chief Marketing Officer at Vodafone Group plc. " " She has also contributed to governance through board roles with organizations such as Cancer Research UK and NHS England. "